Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8+ cytotoxic T lymphocyte responses induced in mucosa-associated tissues

Virology

Volumn 254, Issue 1, 1999, Pages 50-60

  Nguyen, Huan H ^a   Moldoveanu, Zina ^a   Novak, Miroslav J ^a   Van Ginkel, Frederik W ^a   Ban, Elisabeth ^a   Kiyono, Hiroshi ^a   McGhee, Jerry R ^a   Mestecky, Jiri ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERVICAL LYMPH NODE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A; LONG TERM MEMORY; MEDIASTINUM LYMPH NODE; MOUSE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SEROTYPING; STATISTICAL ANALYSIS;

EID: 0033080256     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9521     Document Type: Article

References (40)

1. Andrew, M. E., and Coupar, B. E. (1988). Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice. Scand. J. Immunol. 28, 81-85.
2. Andrew, M. E., Coupar, B. E., Boyle, D. B., and Ada, G. L. (1987). The roles of influenza virus haemagglutinin and nucleoprotein in protection: Analysis using vaccinia virus recombinants. Scand. J. Immunol. 25, 21-28.
3. Askonas, B. A., McMichael, A. J., and Webster, R. G. (1982). The immune response to influenza viruses and problem of protection against infection. In "Basic and Applied Influenza Research" (A. S. Beare, Ed.), p. 159. CRC Press, Boca Raton, FL.
4. Bender, B. S., Bell, W. E., Taylor, S., and Small, P. A., Jr. (1994). Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza. J. Infect. Dis. 170, 1195-1200.
5. Bennink, J., Effros, R. B., and Doherty, P. C. (1978). Influenzal pneumonia: Early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. Immunology 35, 503-509.
6. Carding, S. R., Allan, W., McMickle, A., and Doherty, P. C. (1993). Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J. Exp. Med. 177, 475-482.
7. Davies, M. D., and Parrott, D. M. (1981). Cytotoxic T cells in small intestine epithelial, lamina propria and lung lymphocytes. Immunology 44, 367-371.
8. + T cells. J. Exp. Med. 174, 875-880.
9. Epstein, S. L., Lo, C. Y., Misplon, J. A., Lawson, C. M., Hendrickson, B. A., Max, E. E., and Subbarao, K. (1997). Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, β2-microglobulin-deficient, and J chain-deficient mice. J. Immunol. 158, 1222-1230.
10. Ernst, P. B., Befus, A. D., and Bienenstock, J. (1985). Leukocytes in the intestinal epithelium: An unusual immunological compartment. Immunol. Today 6, 50-55.
11. Gallichan, W. S., Johnson, D. C., Graham, F. L., and Rosenthal, K. J. (1993). Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect Dis. 168, 622-629.
12. Gallichan, W. S., and Rosenthal, K. L. (1996). Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J. Exp. Mod. 184, 1879-1890.
13. + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J. Immunol. 150, 5494-5500.
14. Lawson, C. M., Bennink, J. R., Restifo, N. P., Yewdell, J. W., and Murphy, B. R. (1994). Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol. 68, 3505-3511.
15. Liang, S., Mozdzanowska, K., Palladino, G., and Gerhard, W. (1994). Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152, 1653-1661.
16. Lin, Y. L., and Askonas, B. A. (1981 ). Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J. Exp. Med. 154, 225-234.
17. Lukacher, A. E., Braciale, V. L., and Braciale, T. J. (1984). In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Mod. 160, 814-826.
18. McDermott, M. R., and Bienenstock, J. (1979). Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122, 1892-1898.
19. McGhee, J. R., Kiyono, H., Michalek, S. M., and Mestecky, J. (1987). Enteric immunization reveals a T cell network for IgA responses and suggests that humans possess a common mucosal immune system. Antonie Van Leeuwenhoek. J. Microbiol. 53, 537-543.
20. McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M., and Kiyono, H. (1992). The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 10, 75-88.
21. Mestecky, J. (1987). The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7, 265-276.
22. Mestecky, J., and Jackson, S. (1994). Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J. Clin. Immunol. 14, 259-272.
23. Offit, P. A., Cunningham, S. L., and Dudzik, K. I. (1991). Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J. Virol. 65, 1318-1324.
24. Offit, P. A., and Dudzik, K. I. (1989). Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J. Virol. 63, 3507-3512.
25. Russell, M. W., Kilian, M., and Lamm, M. E. (1999). Biological activities of IgA. In "Handbook of Mucosal Immunology" (P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, and J. R. McGhee, Eds.), 2nd ed., pp. 79-85. Academic Press, San Diego.
26. Sarmiento, M., Dialynas, D. P., Lancki, D. W., Wall, K. A., Lorber, M. I., Loken, M. R., and Fitch, F. W. (1982). Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68, 135-169. [Review]
27. Sarmiento, M., Glasebrook, A. L., and Fitch, F. W. (1980). IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125, 2665-2672.
28. Schulman, J. L., and Kilbourne, E. D. (1965). Induction of partial specific heterotypic immunity in mice by a single infection with influenza virus. J. Bacteriol. 89, 170-174.
29. Taylor, P. M., and Askonas, B. A. (1986). Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58, 417-420.
30. Taylor, P. M., Davey, J., Howland, K., Rothbard, J. B., and Askonas, B. A. (1987). Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. Immunogenetics 26, 267-272.
31. Tite, J. P., Hughes-Jenkins, C., O'Callaghan, D., Dougan, G., Russell, S. M., Gao, X. M., and Liew, F. Y. (1990). Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. Immunology 71, 202-207.
32. Townsend, A. R. M., McMichael, A. J., Carter, N. P., Huddleston, J. A., and Brownlee, G. G. (1984). Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 9, 13-25.
33. Webster, R. G., and Hinshaw, V. S. (1977). Matrix protein from influenza A virus and its role in cross-protection in mice. Infect. Immun. 17, 561-566.
34. Webster, R. G., Kawaoka, Y., Taylor, J., Weinberg, R., and Paoletti, E. (1991). Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9, 303-308.
35. Wells, M. A., Daniel, S., Djeu, J. Y., Kiley, S. C., and Ennis, F. A. (1983). Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes. J. Immunol. 130, 2908-2914.
36. Wraith, D. C., Vessey, A. E., and Askonas, B. A. (1987). Purified influenza virus nucleoprotein protects mice from lethal infection. J. Gen. Virol. 68, 433-440.
37. Yap, K. L., and Ada, G. L. (1978). The recovery of mice from influenza virus infection: Adoptive transfer of immunity with immune T lymphocytes. Scand J. Immunol. 7, 389-397.
38. Yap, K. L., Ada, G. L., and McKenzie, I. F. (1978). Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273, 238-239.
39. Yetter, R. A., Lehrer, S., Ramphai, R., and Small, P. A. (1980). Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity. Infect. Immun. 29, 654-662.
40. Yewdell, J. W., Bennink, J. R., Smith, G. L., and Moss, B. (1985). Influenza virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 82, 1785-1789.